If reactions persist at one site, try a different area
The strongest dose-response was observed for weight loss
Macrogol is an osmotic laxative that draws water into the bowel to soften stools and is recommended by NICE as first-line treatment for chronic constipation in adults Constipation affects 1-10% of Ozempic users and over 10% of Wegovy users, caused by semaglutide's effect on gastrointestinal motility Bulk-forming laxatives like ispaghula husk may suit mild constipation but require adequate fluid intake to prevent obstruction Stimulant laxatives such as senna or bisacodyl provide short-term relief for severe constipation and should be used under medical supervision No specific laxative interactions with Ozempic are documented, but patients should inform healthcare providers of all medications taken Persistent or severe constipation, abdominal pain, vomiting, or inability to pass stool requires urgent medical assessment Not sure where to start
(If a patient is transitioning from another drug for weight loss, healthcare providers can consider their baseline BMI at the start of any drug therapy)
Its ability to mimic the hormone glucagon-like peptide-1 (GLP-1) is crucial in regulating appetite and food intake
Why this matters This approval marks Sun Pharma's second market, after India, for its generic semaglutide, underscoring its growing international reach in complex generic medicines
)
